Total Funding
62
74
Total FundingPost-IPO Debt raised
Growth Score 62 in past quarter
-2 pts
Heat Score 74 in past quarter
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
54207
CellBion specializes in radiopharmaceuticals and radioligand therapy.
About the Company
CellBion specializes in radiopharmaceuticals and radioligand therapy. The company's services include diagnostic drug and medication research and development for cardiovascular diseases, inflammation, prostate cancer, imaging agents for bones, and kidney scintigraphy.